Randomized, Prospective Trial of Customized Neoadjuvant versus Standard Chemotherapy Gets Underway.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 14, doi. 10.1177/155989771403009
- By:
- Publication type:
- Article
Works by Buckley, Rita
Results: 170
1
2
Progression-Free Survival Not Improved with Cabazitaxel versus Topotecan in Refractory SCLC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 13, doi. 10.1177/155989771403008
- By:
- Publication type:
- Article
3
No Significant Difference in Treatment versus Supportive Care in Stage IV NSCLC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 10, doi. 10.1177/155989771403005
- By:
- Publication type:
- Article
4
Downregulation of ERCC1 Boosts Efficacy of Platinum-Based NSCLC Chemotherapy.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 8, doi. 10.1177/155989771403003
- By:
- Publication type:
- Article
5
Next Generation Stents and Scaffolds: Differences in Vascular Response?
- Published in:
- MD Conference Express, 2013, p. 28, doi. 10.1177/155989771319013
- By:
- Publication type:
- Article
6
Anticoagulant Treatment Requires Special Care in the Elderly.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 30, doi. 10.1177/155989771313016
- By:
- Publication type:
- Article
7
Phenotyping and Genotyping of Platelet Disorders.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 29, doi. 10.1177/155989771313015
- By:
- Publication type:
- Article
8
TAFI(a) Assays Measure Extent of Activation in Patient Populations.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 28, doi. 10.1177/155989771313014
- By:
- Publication type:
- Article
9
Complement Inactive in E. coli Shiga Toxin-Producing Diseases.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 16, doi. 10.1177/155989771313009
- By:
- Publication type:
- Article
10
Novel Therapeutics May Lower LDL in Familial Hypercholesterolemia.
- Published in:
- MD Conference Express, 2013, p. 30
- By:
- Publication type:
- Article
11
Eplerenone Post Myocardial Infarction Plus Standard Treatment May Prevent Adverse Cardiovascular Outcomes.
- Published in:
- MD Conference Express, 2013, p. 20
- By:
- Publication type:
- Article
12
Digoxin Reduces 30-Day Hospital Admission in Older Ambulatory Patients With Heart Failure.
- Published in:
- MD Conference Express, 2013, p. 22
- By:
- Publication type:
- Article
13
The TACT Trial: Provocative Results for High-Dose Vitamins and Chelation Therapy.
- Published in:
- MD Conference Express, 2013, p. 16
- By:
- Publication type:
- Article
14
2012 ACR Classification Criteria and Preliminary Guidelines for Sjögren's Syndrome.
- Published in:
- MD Conference Express, 2012, p. 31, doi. 10.1177/155989771219025
- By:
- Publication type:
- Article
15
Thrombosis and Lymphoma Stalk Lupus Patients.
- Published in:
- MD Conference Express, 2012, p. 23, doi. 10.1177/155989771219021
- By:
- Publication type:
- Article
16
Head-to-Head Biologics Trial Shows No Difference Between Abatacept and Adalimumab.
- Published in:
- MD Conference Express, 2012, p. 15, doi. 10.1177/155989771219011
- By:
- Publication type:
- Article
17
Apolipoprotein G1 and G2 Variants May Partially Explain a Higher Prevalence of Lupus-Nephritis ESRD in African Americans.
- Published in:
- MD Conference Express, 2012, p. 10, doi. 10.1177/155989771219004
- By:
- Publication type:
- Article
18
Controversies in Structural Heart Disease.
- Published in:
- MD Conference Express, 2012, p. 34, doi. 10.1177/155989771217018
- By:
- Publication type:
- Article
19
Renal Denervation: A Potential Game-Changing Approach to the Treatment of Resistant Hypertension and More.
- Published in:
- MD Conference Express, 2012, p. 30, doi. 10.1177/155989771217016
- By:
- Publication type:
- Article
20
Benefit of PFO Closure in Cryptogenic Stroke Remains Elusive.
- Published in:
- MD Conference Express, 2012, p. 25, doi. 10.1177/155989771217013
- By:
- Publication type:
- Article
21
PARTNER B Shows Excellent Survival Rates in Inoperable TAVR Patients.
- Published in:
- MD Conference Express, 2012, p. 23, doi. 10.1177/155989771217011
- By:
- Publication type:
- Article
22
POSEIDON: Cutting the Risk of Contrast Nephropathy.
- Published in:
- MD Conference Express, 2012, p. 17, doi. 10.1177/155989771217005
- By:
- Publication type:
- Article
23
Novel Mesh-Covered Stent Improves Rates of Complete ST-Segment Resolution.
- Published in:
- MD Conference Express, 2012, p. 16, doi. 10.1177/155989771217004
- By:
- Publication type:
- Article
24
Cardiovascular Innovations: The Future Is Now.
- Published in:
- MD Conference Express, 2012, p. 28, doi. 10.1177/155989771218018
- By:
- Publication type:
- Article
25
CARRESS-HF: Ultrafiltration Not Superior to Pharmacologic Therapy in the Treatment of Acute Heart Failure.
- Published in:
- MD Conference Express, 2012, p. 24, doi. 10.1177/155989771218015
- By:
- Publication type:
- Article
26
MADIT-RIT: ICD Programming Change Reduces Inappropriate Therapy and All-Cause Mortality.
- Published in:
- MD Conference Express, 2012, p. 21, doi. 10.1177/155989771218012
- By:
- Publication type:
- Article
27
ASPIRE: Using Aspirin to Prevent Recurrence of VTE.
- Published in:
- MD Conference Express, 2012, p. 13, doi. 10.1177/155989771218007
- By:
- Publication type:
- Article
28
OPERA: Omega-3 Fatty Acids Fail to Prevent Postoperative Atrial Fibrillation.
- Published in:
- MD Conference Express, 2012, p. 10, doi. 10.1177/155989771218004
- By:
- Publication type:
- Article
29
The FREEDOM Trial: CABG Superior to PCI in Diabetic Patients with CAD.
- Published in:
- MD Conference Express, 2012, p. 8, doi. 10.1177/155989771218002
- By:
- Publication type:
- Article
30
Hypertension and Renal Function Are Risk Factors for CAD in Type 1 Diabetes.
- Published in:
- MD Conference Express, 2012, p. 34, doi. 10.1177/155989771216017
- By:
- Publication type:
- Article
31
Extending the Reach of GLP-1.
- Published in:
- MD Conference Express, 2012, p. 28, doi. 10.1177/155989771216014
- By:
- Publication type:
- Article
32
Novel Oral Agents: The Search for Transformational Medicines.
- Published in:
- MD Conference Express, 2012, p. 26, doi. 10.1177/155989771216013
- By:
- Publication type:
- Article
33
Diabetes and Enterovirus Infection: The Evidence and Implications.
- Published in:
- MD Conference Express, 2012, p. 24, doi. 10.1177/155989771216012
- By:
- Publication type:
- Article
34
The Challenges of Pharmaceutical Management of Painful Diabetic Peripheral Neuropathy.
- Published in:
- MD Conference Express, 2012, p. 23, doi. 10.1177/155989771216011
- By:
- Publication type:
- Article
35
New ADA/EASD Guidelines Focus on Patient-Centered Care.
- Published in:
- MD Conference Express, 2012, p. 9, doi. 10.1177/155989771216002
- By:
- Publication type:
- Article
36
Exenatide Once Weekly Sustained Improvement in Glycemic Control with Weight Loss Through 4 Years.
- Published in:
- MD Conference Express, 2012, p. 13, doi. 10.1177/155989771216004
- By:
- Publication type:
- Article
37
ORIGIN Trial: Insulin Glargine and n-3 Fatty Acids Neither Reduces CV Events Nor Increases Cancers in Diabetic Patients.
- Published in:
- MD Conference Express, 2012, p. 12, doi. 10.1177/155989771216003
- By:
- Publication type:
- Article
38
Linagliptin Proves Safe and Effective as Add-on Therapy to Basal Insulin.
- Published in:
- MD Conference Express, 2012, p. 15, doi. 10.1177/155989771216006
- By:
- Publication type:
- Article
39
Beyond Weight Loss: Rethinking Treatment Strategies for Obesity.
- Published in:
- MD Conference Express, 2012, p. 12, doi. 10.1177/155989771211007
- By:
- Publication type:
- Article
40
Mechanisms and Consequences of Ectopic Fat Accumulation.
- Published in:
- MD Conference Express, 2012, p. 11, doi. 10.1177/155989771211006
- By:
- Publication type:
- Article
41
Visceral Adipose Tissue and Cardiometabolic Risk.
- Published in:
- MD Conference Express, 2012, p. 10, doi. 10.1177/155989771211005
- By:
- Publication type:
- Article
42
Taking Action on Excess Visceral Fat.
- Published in:
- MD Conference Express, 2012, p. 8, doi. 10.1177/155989771211003
- By:
- Publication type:
- Article
43
Visceral Adiposity Related to Cardiometabolic Risk and Type 2 Diabetes.
- Published in:
- MD Conference Express, 2012, p. 6, doi. 10.1177/155989771211002
- By:
- Publication type:
- Article
44
The Challenges of Predicting Risk: Diabetes and Cardiovascular Disease.
- Published in:
- MD Conference Express, 2012, p. 4, doi. 10.1177/155989771211001
- By:
- Publication type:
- Article
45
LITHE Study Subset: Identification of Tocilizumab Early Response-Associated Biomarkers.
- Published in:
- MD Conference Express, 2012, p. 15, doi. 10.1177/155989771209012
- By:
- Publication type:
- Article
46
New Anti-Diabetes Agents Offer Promise in the Fight Against CVD.
- Published in:
- MD Conference Express, 2012, p. 38
- By:
- Publication type:
- Article
47
Neutral Outcomes But Important Insights From FOCUS-CCTRN.
- Published in:
- MD Conference Express, 2012, p. 26
- By:
- Publication type:
- Article
48
New Monoclonal Antibody to PCSK9 Markedly Lowers LDL-C in Patients on Atorvastatin.
- Published in:
- MD Conference Express, 2012, p. 24
- By:
- Publication type:
- Article
49
Elective PCI at Community Hospitals With Versus Without On-Site Surgery.
- Published in:
- MD Conference Express, 2012, p. 21
- By:
- Publication type:
- Article
50
ROMICAT II: More Data Evaluating CTFirst for Acute Chest Pain ED Triage.
- Published in:
- MD Conference Express, 2012, p. 20
- By:
- Publication type:
- Article